The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anlotinib versus placebo as adjuvant therapy for completely resected high-grade soft tissue sarcomas: Interim results of a phase 2, double-blinded, randomized controlled trial.
 
Chun-Meng Wang
No Relationships to Disclose
 
Xianglin Hu
No Relationships to Disclose
 
Ling-ge Yang
No Relationships to Disclose
 
Yu Xu
No Relationships to Disclose
 
Wen-Ding Huang
No Relationships to Disclose
 
Jian-rong Zhang
No Relationships to Disclose
 
Zheng-Wang Sun
No Relationships to Disclose
 
Mo Chen
No Relationships to Disclose
 
Bi-qiang Zheng
No Relationships to Disclose
 
Sheng-jian Zhang
No Relationships to Disclose
 
Lin Yu
No Relationships to Disclose
 
Tomohiro Fujiwara
No Relationships to Disclose
 
Yong Chen
No Relationships to Disclose
 
Yang-bai Sun
No Relationships to Disclose
 
Matthew T. Houdek
Consulting or Advisory Role - InhibRx; LINK Medical
 
Wangjun Yan
No Relationships to Disclose